Accelerating precision medicine™

Press Releases

August 6, 2020
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development (PDF)
June 22, 2020
Caprion–HistoGeneX is offering molecular COVID-19 testing services while expanding its biomarker capabilities (PDF)
April 23, 2020
Caprion-HistoGeneX expands its biomarker capabilities and deploys molecular COVID-19 testing services (PDF)
October 29, 2019
Caprion Biosciences Leads Pre-Conference Workshop on Best Practices for Biomarkers Validation at Upcoming AAPS PharmaSci 360 Conference
July 31, 2019
Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development
April 30, 2019
Caprion Acquires Serametrix and Expands its Biomarker and Immune Monitoring Franchise (PDF)
April 25, 2019
Roche Presented Caprion Biosciences’ Data on Targeted Mass Spectrometry for Clinical Proteomics (PDF)
January 8, 2019
Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring (PDF)
August 20, 2018
Caprion Biosciences Expands its Biomarker and Immune Monitoring Franchise by Acquiring US-Based Primity Bio (PDF)
September 13, 2017
Caprion Biosciences Receives College of American Pathologists (CAP) Accreditation & Clinical Laboratory Improvement Amendments (CLIA) Certification (PDF)
August 23, 2017
Caprion Biosciences and the FNIH Biomarkers Consortium Partner to Improve Monitoring of Early Alzheimer’s Disease Progression and Treatment Response (PDF)
July 27, 2017
Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections. (PDF)
May 10, 2017
Caprion Biosciences Inc. will present at the 5th Annual Biopharmaceutical Emerging Best Practices Association (BEBPA) Conference highlighting the latest developments in Host Cell Protein (HCP) analysis (PDF)
April 7, 2017
Caprion to Present Advantages And Challenges of Protein Biomarker Analysis By Mass Spectrometry With FFPE Samples From Cancer Patients, at the 11th Annual WRIB (Workshop on Recent Issues in Bioanalysis) Conference in Los Angeles, April 4-7,2017 (PDF)
February 17, 2017
Caprion Biosciences to Lead Short Course and Present Poster at Molecular Medicine Tri-Conference in San Francisco: Intracellular Cytokine Detection Assay in Adoptive Cell Therapy Trials and Metaproteomic Analysis of Gut Microbiome in Infants (PDF)
February 16, 2017
Caprion Biosciences to Present Poster at Biologic Manufacturing Asia on Host Cell Protein (HCP) Identification and Quantification Using Mass Spectrometry (PDF)
October 4, 2016
Caprion Bioscience to Present “Analytical Challenges and Strategies of Using MRM/MS-Based Methods for Biomarker Development” (PDF)
September 13, 2016
Caprion Biosciences Acquires the Immune Monitoring Laboratory from ImmuneHealth (PDF)
September 2, 2016
NIH Grant to Fund Research on Proteomics, Immunoassay for TB Activation in HIV Patients (PDF)
July 20, 2016
Caprion Biosciences Acquired by GHO Capital (PDF)
April 26, 2016
Caprion Biosciences to Present Two Posters at the Annual PEGS Conference in Boston (PDF)
February 2, 2016
Caprion Biosciences to Present "Direct Identification of Neo-epitopes for Cancer Vaccines and Adoptive T-Cell Therapies" (PDF)
January 26, 2016
Caprion Co-authors NATURE COMMUNICATIONS Publication Revealing Predictive Biomarkers of Response to HBV Vaccines (PDF)
October 27, 2015
Caprion Poster Presentation at the 2015 AAPS Annual Meeting: Development of a Novel P700 Plasma Peptidomic Platform (PDF)
October 14, 2015
Caprion to Present at BioJapan 2015 World Business Forum (PDF)
May 14, 2015
Caprion to Present “Identification and Quantification of Host Cell Proteins by LC-MS/MS and LC-MRM” (PDF)
May 13, 2015
Caprion/ImmuneCarta Highlights Data Presented by Adaptimmune at the 2015 American Society of Gene and Cell Therapy Annual Meeting (PDF)
February 3, 2015
December 10, 2014
Three New Companies Join Cancer Research UK-Abcodia Collaboration to Identify Blood Markers for Early Cancer Detection (PDF)
November 12, 2014
Data Reveals Plant-Made Flu Vaccine Demonstrates Ability to Elicit Strong T-Cell Immune Response (PDF)
October 9, 2014
Caprion Highlights Recently Published Data on Strengthening Immune Response in HIV Utilizing CD160 and PD1-Targeted Antibodies (PDF)
September 18, 2014
Caprion to Present Data on Protein Biomarkers Expressed in Alzheimer’s and Schizophrenia Patients at the CNS Diseases World Summit (PDF)
September 9, 2014
Caprion Receives Grant from The Michael J. Fox Foundation to Identify Parkinson's Disease Biomarkers (PDF)
August 19, 2014
iCo Therapeutics Announces Positive Oral Amphotericin B Study Results (PDF)
August 18, 2014
Caprion Presented Case Studies Demonstrating how Multiparametric Flow Cytometry is Applied during Pre-clinical and Clinical Development (PDF)
August 6, 2014
Caprion to Present Case Study on Role of Immune Monitoring in Pre-Clinical Development and Phase I/II Trials at ImVac Summit (PDF)
May 20, 2014
Caprion to Present Data on Two New Assays at 2014 AAPS National Biotechnology Conference (PDF)
April 29, 2014
Caprion Introduces CNS ProteoCartaTM—Customizable and Highly Multiplexed Assay for Studying Neurological Disease
April 3, 2014
Caprion to Present Immune Response Results from Phase 1 Study in Ovarian Cancer Patients at 2014 AACR Annual Meeting. (PDF)
March 10, 2014
Global Genomics Group (G3) and Caprion to Partner on GLOBAL Study to Identify Cardiovascular Disease Biomarkers and Drug Targets (PDF)
October 28, 2013
LaPresse Montreal newspaper articles (in French): "Lung cancer - A test to avoid biopsies" and "Martin Lebanc - Personality of the week"
October 16, 2013
Caprion Collaboration with Indi on Development of Blood-Based Diagnostic for Lung Cancer Yields Publication in Science Translational Medicine
February 15, 2013
July 23, 2012
Chicago Growth Partners Leads Growth Buyout of Caprion Proteomics
June 4, 2012
“Caprion’s New Solutions for Highly Multiplexed Protein Assays via MRM” Webinar on June 4, 2012 (archive and slides now available.)
October 31, 2011
Martin LeBlanc interview in La Presse newspaper (in French) (PDF)
October 21, 2010
Caprion Proteomics identifies promising new candidate biomarkers to predict response to hepatitis C treatment
March 25, 2009
Caprion article in Genetic Engineering & biotechnology News: "Personalized Medicine Grows in Fits and Starts" March 1st 2009 issue (Volume 29, Number 5)
December 16, 2008
Caprion Proteomics inc. announces strategic marketing and distribution alliance with Covance inc.
December 16, 2008
Covance purchases equity stake in Caprion Proteomics
December 13, 2008
Dr Joanna Hunter featured as one of the 8 most indispensable business women in Québec, by Premieres en
October 3, 2008
The National Institute of Allergy and Infectious Diseases (NIAID) a part of the US National Institutes of Health, awards Caprion a $12.9M US Infectious Disease Biomarker Research Contract. (PDF)
July 11, 2008
Drug Discovery & Development magizine article - July 01, 2008 "Genes lead to proteins, yes, but there's something more beyond translation. You need the protein sequence."
January 15, 2008
Caprion article in Genetic Engineering & biotechnology News: "Capitalizing on Biomarker Discovery Work" January 15th 2008 issue (Volume 28, Number 2)
January 1, 2008
Caprion article in Genetic Engineering & biotechnology News: "Unlocking the Secrets of Protein Profiling" January 1st 2008 issue (Volume 28, Number 1)
July 11, 2007
Great Point Partners announce acquisition of a majority stake in Caprion Proteomics.
June 28, 2007
Thallion Announces Sale of Majority Stake in Caprion Proteomics to Great Point Partners
June 6, 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
March 13, 2007
Caprion and Ecopia complete combination and announce closing of $45 million private placement: New entity called Thallion Pharmaceuticals Inc. Caprion Proteomics is established.
March 12, 2007
Caprion and Ecopia Shareholders Approve Amalgamation and Related Transactions
February 19, 2007
Caprion and Ecopia Announce Commitments of $45 Million in Connection with Private Placement
January 4, 2007
Ecopia announces agreement with caprion to combine their businesses and launch a $30 million private placement
October 25, 2006
Caprion Pharmaceuticals Announces Expansion of Biomarker Discovery Collaboration with Vertex Pharmaceuticals
October 11, 2006
Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with Centocor Research and Development, Inc.
September 22, 2006
Caprion Pharmaceuticals Inc. Named One of Canada’s Fastest Growing Companies in 2006 Deloitte Life Sciences Fast 15 Program
September 19, 2006
Caprion Announces Completion of Phase I Clinical Studies for its Shigatoxin-producing E. coli Therapy
March 29, 2006
Caprion Pharmaceuticals Announces New Biomarker Discovery Collaboration with Vertex Pharmaceuticals
January 24, 2006
Caprion Pharmaceuticals Announces Biomarker Discovery Collaboration with Berlex Biosciences
January 18, 2006
Caprion Pharmaceuticals Announces Biomarker Discovery Collaboration with ICOS Corporation
January 10, 2006
Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with ImClone Systems
November 1, 2005
Caprion Pharmaceuticals Announces New Collabration With AstraZeneca
July 12, 2005
Caprion Pharmaceuticals Announces Biomarker Research Collaboration With Boehringer Ingelheim
June 28, 2005
Wyeth Expands Caprion Biomarker Collaborations to Include Two Clinical Biomarker Programs
March 31, 2005
ICOS Corporation And Caprion Pharmaceuticals Enter Into Joint Development Collaboration
March 21, 2005
Caprion completes key milestone early in Oncology Discovery collaboration with Abbott
June 7, 2004
Caprion Pharmaceuticals acquires therapeutic antibody clinical program and antibody technologies from Sunol Molecular
February 4, 2004
Abbott Laboratories And Caprion Pharmaceuticals Announce Drug Discovery Collaboration In Oncology
September 24, 2003
New discovery provides a basis for the development of more effective vaccines against infectious disease and cancer
August 11, 2003
Caprion Pharmaceuticals Announces Disease Biomarker Research Collaboration with AstraZeneca
July 16, 2003
Caprion Pharmaceuticals and Wyeth Announce Biomarker Research Collaboration
June 1, 2003
Researchers Discover Possible Diagnostic, Therapy, Vaccine For Mad Cow and Other Prion Diseases


Accreditations & Certifications

CAP accreditation and CLIA certification

CAP Accredited


+1 514.360.3600
+1 877.776.3443
141 President Kennedy Ave., Suite SB-5658
Montreal, Quebec


Primity Bio
48383 Fremont Blvd
Suite 118
Fremont, CA 94538
Tel.: +1 858.229.2529

2235 Farraday Ave,Suite N,
Carlsbad, CA, 92008, USA
Tel: +1 760 652 4060

1331 W 75th St #401,
Naperville, IL 60540, USA
Tel: +1 630-473-6655


Serametrix Party Limited
Suite 4/54-60 Briggs Street
Camperdown, NSW, 2050
+61 2 9168 5908


Caprion Biosciences Inc.
+32 (0) 71 96 23 36
8 rue Adrienne Bolland
6041 Gosselies

Unit 22, Surrey Technology Centre,
40 Occam Road,
Guildford, Surrey, UK
Tel: +44 1483 685599

Antwerp, Belgium
Sint-Bavostraat 78
2610 Antwerpen (Wilrijk)
Tel: +32 3 50 20 500
Sample Reception: +32 3 50 20 620
Shipments: +32 3 50 20 625


201 President Kennedy Ave., Suite PK-3900
Montreal, Quebec
+1 514.360.3600
+1 877.776.3443

Follow us



+1 877.776.3443